Effect of antiviral therapy on the occurrence of hepatitis B-related hepatocellular carcinoma / 中华肝脏病杂志
Chinese Journal of Hepatology
; (12): 721-724, 2019.
Article
en Zh
| WPRIM
| ID: wpr-797929
Biblioteca responsable:
WPRO
ABSTRACT
Clinically, hepatocellular carcinoma (HCC) is one of the most common malignant tumors with a high rate of morbidity and mortality. Hepatitis B virus infection is the main cause of hepatocellular carcinoma in China and it is a serious threat to people's health. Antiviral drugs such as nucleos(t)ide analogues and interferon can inhibit viral replication and liver fibrosis progression and reduce the occurrence of hepatitis B-related HCC. This article reviews the effects of different antiviral therapy on the occurrence of hepatitis B-related hepatocellular carcinoma in recent years.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Hepatology
Año:
2019
Tipo del documento:
Article